Advertisement
News
Subscribe to MDT Magazine News

W. L. Gore & Associates Continues Its Tradition as One of Nation's Best Workplaces

January 20, 2011 8:46 am | by Bio-Medicine.Org | Comments

NEWARK, Del., Jan. 20, 2011  /- With its unique, non-hierarchical, team-based culture, global manufacturing company W. L. Gore & Associates has once again earned a spot on FORTUNE magazine's annual list of the 100 Best Companies to Work for in America. The company is ranked No....

TOPICS:

TheCarrot.com Launches Quit Smoking Program

January 20, 2011 8:46 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, Jan. 20, 2011 /- TheCarrot.com , a leading provider of online and mobile consumer health engagement programs, announced the immediate availability of its new Quit Smoking Program. Drawing on the expertise of the University of California at San Francisco's Smoking Cessation...

TOPICS:

State of the Medicare Mobility Benefit

January 20, 2011 8:45 am | by Bio-Medicine.Org | Comments

WASHINGTON, Jan. 20, 2011 /PRNewswire-USNewswire/ -- The State of the Medicare Mobility Benefit has never been more troubling, and perplexing. For much of the last decade, Congress and regulators implemented policies and regulations limiting the effectiveness of the Medicare benefit that...

TOPICS:
Advertisement

Summary Box: UnitedHealth 4Q profit rises 10 pct

January 20, 2011 7:45 am | by The Associated Press | Comments

PROFIT GROWTH: UnitedHealth Group's fourth-quarter profit rose 10 percent to $1.04 billion, or 94 cents per share, compared with the same quarter of 2009. Revenue increased 10 percent to $24.03 billion.WALL STREET BEAT: Analysts polled by FactSet were expecting, on average, earnings of 84 cents per...

Genzyme expands Belgium manufacturing plant

January 20, 2011 6:50 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. plans to build a manufacturing plant in Geel, Belgium, to aid growing production of its Pompe disease drug, Lumizyme, which had been produced in the company's Allston plant prior to its temporary shutdown in the summer of 2009.

Featured Search — The Value of Experience in Breast Cancer Diagnosis

January 20, 2011 6:33 am | by Diagnostic Imaging | Comments

Radiologists at Cambridge University Hospital found that more experienced radiologists are far better at detecting breast malignancy.

TOPICS:

InformexUSA 2011 Projects Record Attendance

January 20, 2011 5:48 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Jan. 20, 2011 /- Informex , the leading meeting place for buyers and sellers of high-value chemistry for a broad range of applications, today announced projections that 2011 will be a record setting year for both attendee and exhibitor numbers at the brand's flagship...

TOPICS:

Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardio...

January 20, 2011 5:44 am | by Bio-Medicine.Org | Comments

CAMBRIDGE, Mass., Jan. 20, 2011 /- Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease...

TOPICS:
Advertisement

Earnings and jobless claims likely to sway stocks

January 20, 2011 4:45 am | by MATTHEW CRAFT - AP Business Writer - Associated Press | Comments

U.S. stocks appear headed for a mixed opening on Thursday, a day after weak earnings gave them their worst drubbing since November.Investors are getting a new round of corporate earnings and economic reports. The Labor Department said Thursday morning that first time claims for unemployment...

Ascension Orthopedics Introduces True Modularity With MOVEMENTâ„¢ Great Toe System

January 20, 2011 4:44 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Jan. 20, 2011 /- Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the expansion of the MOVEMENT™ Great Toe Implant System to include a total arthroplasty component. This complete great toe arthroplasty system now allows surgeons the...

TOPICS:

Spherix Announces Registered Direct Offering of $2.77 Million

January 20, 2011 4:43 am | by Bio-Medicine.Org | Comments

BETHESDA, Md., Jan. 20, 2011 /- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical...

TOPICS:

Reportlinker Adds Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

January 20, 2011 3:39 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

TOPICS:

Reportlinker Adds Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

January 20, 2011 3:38 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

TOPICS:

Reportlinker Adds Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

January 20, 2011 3:38 am | by Bio-Medicine.Org | Comments

NEW YORK, Jan. 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

TOPICS:

FDA Plans to Improve Review Path for Medical Devices

January 20, 2011 3:33 am | by Diagnostic Imaging | Comments

The FDA this week outlined a plan to improve the path to market for medical devices, including streamlining the review for low-risk devices and clarifying when clinical data should be submitted. The agency is deferring some of the contentious decisions, giving the Institute of Medicine a...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading